Beijing Biostar Pharms Co Ltd (02563.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.7x

Market Cap

HKD 806.20M

MomentumView details →

1D Return

−0.27%

YTD Return

−23.93%

RSI (14)

59.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.7x

Market Cap

HKD 806.20M

RSI (14)

59.9

MomentumView details →

1D Return

−0.27%

YTD Return

−23.93%

ProfitabilityView details →

Gross Margin

92.47%

Net Margin

−192.97%

EBITDA Margin

−164.25%

ROE (TTM)

−16.86%

ROA (TTM)

−14.56%

Asset Turnover

0.08x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−0.23%

EPS CAGR 3Y

+9.30%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

8.77x

Quick Ratio

8.00x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

64.58M

Net Income (TTM)

−124.61M

Op. CF (TTM)

−63.63M

Latest newsMore news →

No recent news for 02563.HK.

Similar companies

Fangzhou Inc.06086.HK Modern Chinese Medicine Group Co., Ltd.01643.HK Bristol-Myers Squibb Company CeCELG-RI TYK Medicines, Inc02410.HK 天目药业600671.SH Organon & Co.OGN Find similar companies →

Latest newsMore news →

No recent news for 02563.HK.